Credit Suisse’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $3.1M | Buy |
|
|||||
|
2023
Q4 | $3.67M | Sell |
|
|||||
|
2023
Q3 | $19.1M | Sell |
|
|||||
|
2023
Q2 | $13.2M | Buy |
|
|||||
|
2023
Q1 | $12.2M | Buy |
|
|||||
|
2022
Q4 | $3.95M | Sell |
|
|||||
|
2022
Q3 | $6.05M | Buy |
|
|||||
|
2022
Q2 | $5.2M | Sell |
|
|||||
|
2022
Q1 | $6.25M | Sell |
|
|||||
|
2021
Q4 | $11.2M | Buy |
|
|||||
|
2021
Q3 | $21.9M | Buy |
|
|||||
|
2021
Q2 | $23.9M | Buy |
|
|||||
|
2021
Q1 | $22.6M | Buy |
|
|||||
|
2020
Q4 | $24.1M | Sell |
|
|||||
|
2020
Q3 | $17.3M | Sell |
|
|||||
|
2020
Q2 | $17.8M | Buy |
|
|||||
|
2020
Q1 | $292K | Sell |
|
|||||
|
2019
Q4 | $780K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $701K | Buy |
|